Ribonucleases as a Novel Pro-Apoptotic Anticancer Strategy: Review of the Preclinical and Clinical Data for Ranpirnase

Author： Costanzi John   Sidransky David   Navon Ami   Goldsweig Howard  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.23, Iss.7, 2005-10, pp. : 643-650

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Forodesine: review of preclinical and clinical data

By Al-Kali Aref   Gandhi Varsha   Ayoubi Mohamad   Keating Michael   Ravandi Farhad  

Future Oncology, Vol. 6, Iss. 8, 2010-08 ,pp. : 1211-1217

Future Medicine

Access to resources Recommend Favorite

Vitespen: a preclinical and clinical review

By Wood Christopher G   Mulders Peter  

Future Oncology, Vol. 5, Iss. 6, 2009-08 ,pp. : 763-774

Future Medicine

Access to resources Recommend Favorite

Pro-Oxidative Action of Polyphenols as Action Mechanism for their Pro-Apoptotic Activity

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 10, 2014-12 ,pp. : 1363-1375

Bentham Science Publishers

Access to resources Recommend Favorite

Curcumin acts anti-proliferative and pro-apoptotic in human meningiomas

By Curic S.  

Journal of Neuro-Oncology, Vol. 113, Iss. 3, 2013-07 ,pp. : 385-396

Springer Publishing Company

Access to resources Recommend Favorite

Down-Regulation of Pro-Apoptotic Genes is an Early Event in the Progression of Malignant Melanoma

By Jensen Eric   Lewis James   McLoughlin James   Alvarado Michael   Daud Adil   Messina Jane   Enkemann Steven   Yeatman Timothy   Sondak Vernon   Riker Adam  

Annals of Surgical Oncology, Vol. 14, Iss. 4, 2007-04 ,pp. : 1416-1423

Springer Publishing Company

Access to resources Recommend Favorite